BSEAdvik Laboratories LtdMinimalNeutral
Announced Tue, 20 Jan · 20:58 IST
Advik Laboratories Ltd - 531686 - Statement Of Investor Complaints For The Quarter Ended 31St December, 2025
Compliance View source PDF
Price reaction · full curve
Awaiting price reaction for this filing.
AI summary
Advik Laboratories Ltd (now renamed MPS Pharmaa Limited) has filed its quarterly investor complaints report with BSE for the October–December 2025 quarter, as required under SEBI Listing Regulations. The company reported zero investor complaints pending at the start of the quarter, zero received during the quarter, zero disposed of, and zero remaining unresolved at the end of the quarter. The filing was signed by Pooja Chuni, Company Secretary, and was also shared with the Ahmedabad Stock Exchange.
Likely market impact
A clean NIL complaints record signals good investor service standards and regulatory compliance, though this is a routine filing with no direct impact on stock price or shareholder value.